Overview
················································
Team
················································
Scientific Advisory Board
················································
Board of Directors
················································
Investors
················································
Events&News
················································

July, 2007
Dr. José Maria Palacios as new President of the Scientific Advisory Board >


17th March, 2007
Crystax wins the award "Emprenedor XXI" sponsored by "La Caixa" to the enterprise with more growing potential >

March, 2006
CENIT approves the funding to the project of R&D Genius Pharma >


7th February, 2006
New DNA structure allows the design of new pharmacological agents >


30th September, 2005
Crystax Pharmaceuticals closes financing round >


9th September, 2005
SERVIER and Crystax Pharmaceuticals sign research collaboration >


23rd February, 2005
Spanish Esteve and other three laboratories form a partnership >


17th December, 2004
Crystax Pharmaceuticals and Uriach sign a contract for new anti-inflammatory drug development >


1st March, 2004
Crystax and Almirall sign a research agreement to study the structure of a pharmaceutical target >


···········································································




 
  New DNA structure allows the design of new pharmacological agents.  
[+]